Boucher CA - Search Results

1

Coronavirus escape from heptad repeat 2 (HR2)-derived peptide entry inhibition as a result of mutations in the HR1 domain of the spike fusion protein.

Bosch BJ, Rossen JW, Bartelink W, Zuurveen SJ, de Haan CA, Duquerroy S, Boucher CA, Rottier PJ. Bosch BJ, et al. Among authors: boucher ca. J Virol. 2008 Mar;82(5):2580-5. doi: 10.1128/JVI.02287-07. Epub 2007 Dec 12. J Virol. 2008. PMID: 18077706 Free PMC article.

2

Evolution of a novel 5-amino-acid insertion in the beta3-beta4 loop of HIV-1 reverse transcriptase.

Huigen MC, de Graaf L, Eggink D, Schuurman R, Müller V, Stamp A, Stammers DK, Boucher CA, Nijhuis M. Huigen MC, et al. Among authors: boucher ca. Virology. 2007 Aug 1;364(2):395-406. doi: 10.1016/j.virol.2007.03.028. Epub 2007 Apr 23. Virology. 2007. PMID: 17451772 Free article.

3

Strengthening the diagnostic capacity to detect Bio Safety Level 3 organisms in unusual respiratory viral outbreaks.

van Asten L, van der Lubben M, van den Wijngaard C, van Pelt W, Verheij R, Jacobi A, Overduin P, Meijer A, Luijt D, Claas E, Hermans M, Melchers W, Rossen J, Schuurman R, Wolffs P, Boucher C, Schirm J, Kroes L, Leenders S, Galama J, Peeters M, van Loon A, Stobberingh E, Schutten M, Koopmans M. van Asten L, et al. J Clin Virol. 2009 Jul;45(3):185-90. doi: 10.1016/j.jcv.2009.05.024. Epub 2009 Jun 6. J Clin Virol. 2009. PMID: 19515608

4

Mutation V111I in HIV-2 reverse transcriptase increases the fitness of the nucleoside analogue-resistant K65R and Q151M viruses.

Deuzing IP, Charpentier C, Wright DW, Matheron S, Paton J, Frentz D, van de Vijver DA, Coveney PV, Descamps D; ANRS CO5 HIV-2 Cohort; Boucher CA, Beerens N. Deuzing IP, et al. Among authors: boucher ca. J Virol. 2015 Jan;89(1):833-43. doi: 10.1128/JVI.02259-14. Epub 2014 Oct 29. J Virol. 2015. PMID: 25355888 Free PMC article.

5

Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management.

Wensing AM, van de Vijver DA, Angarano G, Asjö B, Balotta C, Boeri E, Camacho R, Chaix ML, Costagliola D, De Luca A, Derdelinckx I, Grossman Z, Hamouda O, Hatzakis A, Hemmer R, Hoepelman A, Horban A, Korn K, Kücherer C, Leitner T, Loveday C, MacRae E, Maljkovic I, de Mendoza C, Meyer L, Nielsen C, Op de Coul EL, Ormaasen V, Paraskevis D, Perrin L, Puchhammer-Stöckl E, Ruiz L, Salminen M, Schmit JC, Schneider F, Schuurman R, Soriano V, Stanczak G, Stanojevic M, Vandamme AM, Van Laethem K, Violin M, Wilbe K, Yerly S, Zazzi M, Boucher CA; SPREAD Programme. Wensing AM, et al. Among authors: boucher ca. J Infect Dis. 2005 Sep 15;192(6):958-66. doi: 10.1086/432916. Epub 2005 Aug 15. J Infect Dis. 2005. PMID: 16107947

6

An increase in viral replicative capacity drives the evolution of protease inhibitor-resistant human immunodeficiency virus type 1 in the absence of drugs.

van Maarseveen NM, de Jong D, Boucher CA, Nijhuis M. van Maarseveen NM, et al. Among authors: boucher ca. J Acquir Immune Defic Syndr. 2006 Jun;42(2):162-8. doi: 10.1097/01.qai.0000219787.65915.56. J Acquir Immune Defic Syndr. 2006. PMID: 16645546

7

Persistence of HIV-1 variants with multiple protease inhibitor (PI)-resistance mutations in the absence of PI therapy can be explained by compensatory fixation.

van Maarseveen NM, Wensing AM, de Jong D, Taconis M, Borleffs JC, Boucher CA, Nijhuis M. van Maarseveen NM, et al. Among authors: boucher ca. J Infect Dis. 2007 Feb 1;195(3):399-409. doi: 10.1086/510533. Epub 2006 Dec 29. J Infect Dis. 2007. PMID: 17205479

8

Ninety-nine is not enough: molecular characterization of inhibitor-resistant human immunodeficiency virus type 1 protease mutants with insertions in the flap region.

Kozísek M, Sasková KG, Rezácová P, Brynda J, van Maarseveen NM, De Jong D, Boucher CA, Kagan RM, Nijhuis M, Konvalinka J. Kozísek M, et al. Among authors: boucher ca. J Virol. 2008 Jun;82(12):5869-78. doi: 10.1128/JVI.02325-07. Epub 2008 Apr 9. J Virol. 2008. PMID: 18400858 Free PMC article.

9

Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy.

Cohen Stuart JW, Velema M, Schuurman R, Boucher CA, Hoepelman AI. Cohen Stuart JW, et al. Among authors: boucher ca. J Med Virol. 2009 Mar;81(3):441-5. doi: 10.1002/jmv.21422. J Med Virol. 2009. PMID: 19152397

10

Evaluation of a rapid molecular algorithm for detection of pandemic influenza A (H1N1) 2009 virus and screening for a key oseltamivir resistance (H275Y) substitution in neuraminidase.

van der Vries E, Jonges M, Herfst S, Maaskant J, Van der Linden A, Guldemeester J, Aron GI, Bestebroer TM, Koopmans M, Meijer A, Fouchier RA, Osterhaus AD, Boucher CA, Schutten M. van der Vries E, et al. Among authors: boucher ca. J Clin Virol. 2010 Jan;47(1):34-7. doi: 10.1016/j.jcv.2009.09.030. Epub 2009 Oct 25. J Clin Virol. 2010. PMID: 19857993 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

505 results

Search Page